References

1. Dicko A, Sagara I, Ellis RD, Miura K, Guindo O, Kamate B, Sogoba M, Niambelé MB, Sissoko M, Baby M, Dolo A, Mullen GED, Fay MP, 2008. Pierce, Diallo DA, Saul A, Miller LH, Doumbo OK. Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children, 2008. PLoS ONE 3 : e1563.
   [Google Scholar]
2. Bell BP, 2002. Global epidemiology of hepatitis A: implications for control strategies. Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. London: International Medical Press, 9–14.
3. Ajdukiewicz A, Mosley JW, 1980. Hepatitis A antibody in West Africa. Lancet 2 : 695.
   [Google Scholar]
4. Barin F, Denis F, Chotard J, Paulin R, Chiron JP, Maupas PH, Goudeau A, Coursaget P, 1980. Early asymptomatic hepatitis A in Senegalese children. Lancet 1 : 212–213.
   [Google Scholar]
5. Hodges M, Sanders E, Aitken C, 1998. Seroprevalence of hepatitis markers: HAV, HBC, HCV, and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 17 : 36–37.
   [Google Scholar]
6. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), 1999. MMWR Morb Mortal Wkly Rep 48 (RR-12): 1–37.
   [Google Scholar]
7. Macete E, Aponte JJ, Guiinovart C, Sacarlal J, Ofori-Anyinam O, Mandomando I, Espasa M, Bevilacqua C, Leach A, Dubois MC, Heppner DG, Tello L, Milman J, Cohen J, Dubovsky F, Tornieporth N, Thompson R, Alonso PL, 2007. Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique. Trop Med Int Health 12 : 37–46.
   [Google Scholar]